Exploring Opportunities in Biotech and Pharma in Switzerland

Joined by the Swedish startups MyCural, Pharmnovo, and Sortina Pharma, our colleague Arwin Zendehrokh attended the conference, which focused on biotech, healthtech, and pharma.

The primary focus of the conference was to facilitate meaningful interactions and collaborations among key players in the life sciences domain. The event brought together over 200 Swiss and Nordic startups, pharmaceutical giants, and investors.

For the startup delegation, this presented a golden opportunity to forge new partnerships, gain industry insights, and showcase their cutting-edge innovations to a diverse audience. They engaged with investors, other life science startups, and Switzerland’s innovation agency, Innosuisse, to gain insights into the local ecosystem.

Follow-up Matchmaking with Swiss Corporates

During the conference, the startups had the opportunity to continue discussions with corporates they had previously met through Ignite during a matchmaking event held last year. This follow-up matchmaking allowed the startups to nurture existing connections, explore synergies, and delve deeper into potential collaboration avenues with Swiss corporations.

“The Nordic countries and Switzerland share many similarities and collaboration opportunities within the life science sector. Delving deeper into each other’s ecosystems is crucial to promoting stronger collaborations, and fostering a tighter dialogue between our stakeholders is key to achieving this. Despite working in diverse ways, there is room for mutual learning, and addressing this aspect can accelerate the commercialization of life-saving innovations,” says Arwin.

This delegation journey wouldn’t have been possible without the cooperation from Business Sweden and Vinnova.